Alzheimer's Imaging Consortium

Alzheimers Dement. 2024 Dec;20 Suppl 9(Suppl 9):e093683. doi: 10.1002/alz.093683.

Abstract

Background: Virtually all adults with Down Syndrome(DS) show Alzheimer's disease(AD)-related pathologic change by the age of 40 years. While sex differences in Aß-dependent tauopathy are apparent during early sporadic AD, sex differences in the DS population remain under-investigated. Moreover, menopause onset occurs earlier in the DS population(45 years), and it remains unknown whether menopause status and hormone therapy(HT) exposure influences Aß-dependent tauopathy in women with DS. In a cognitively unimpaired DS population, we investigated cross-sectional associations between Aß and regional tau as a function of sex, menopause-status, and HT-exposure.

Method: 115 cognitively unimpaired individuals from the Alzheimer Biomarkers Consortium-Down Syndrome (Mean Age 37.9; 56 women [48%]; 13 APOEe4 carriers [11%];Table 1) underwent Pittsburgh Compound-B/Florbetapir(Aß-PET) and Flortaucipir(tau-PET). Global Aß was transformed to centiloid scale. 10 (20.6%) women self-reported as being menopausal. 11 (20.4%) women reported HT exposure. Four a priori tau regions previously demonstrating sex differences in sporadic AD were selected (entorhinal cortex, inferior temporal gyrus, fusiform gyrus, lateral occipital cortex). Linear regressions (covarying age) examined the sex*Aß interaction for each tau-PET outcome. Similar models were examined in the subset of women, investigating menopause-status[not menopausal/menopausal]*Aß and HT*Aß interactions. Exploratory whole-brain vertex-wise tau-PET analyses were conducted with sex*Aß and menopause*Aß (modelled-separately) and a FDR threshold p = 0.05.

Result: The sex*Aß interaction showed a trend level association with tau-PET, suggesting men exhibit elevated posterior-temporal and lateral-occipital tau with higher Aß, relative to women (Fig 1). The menopause status*Aß analyses indicated that menopausal women with higher Aß exhibit significantly elevated temporal, lateral occipital and parietal tau (Fig 2). Sensitivity analyses covarying an age*Aß interaction suggested that the menopause-tau association was not driven solely by advancing age. Finally, higher temporal fusiform (p = 0.020) and lateral occipital (p = 0.004) tau-PET signal was observed in women with HT-exposure at higher levels of Aß, relative to women without exposure.

Conclusion: Sex differences in the Aß-tau association were marginal and require additional investigation. Menopause-status and HT-exposure influenced the association between Aß and regional tau. While our results lack statistical power and should be replicated in larger DS populations, the findings suggest that sex-specific biomarker profiles in DS may help determine sex-specific pathways and hormonal mechanisms underlying increased risk of dementia.

MeSH terms

  • Adult
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides* / metabolism
  • Aniline Compounds
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Cross-Sectional Studies
  • Down Syndrome / diagnostic imaging
  • Down Syndrome / metabolism
  • Ethylene Glycols
  • Female
  • Humans
  • Male
  • Menopause
  • Middle Aged
  • Positron-Emission Tomography*
  • Sex Factors
  • Thiazoles
  • tau Proteins* / metabolism

Substances

  • tau Proteins
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Thiazoles
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • florbetapir
  • Ethylene Glycols